Rapid Dose Therapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Mark Upsdell
Chief executive officer
CA$155.6k
Total compensation
| CEO salary percentage | 96.4% |
| CEO tenure | 7yrs |
| CEO ownership | 9.9% |
| Management average tenure | 5.6yrs |
| Board average tenure | 1.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Nov 30 2023 | n/a | n/a | -CA$4m |
| Aug 31 2023 | n/a | n/a | -CA$3m |
| May 31 2023 | n/a | n/a | -CA$3m |
| Feb 28 2023 | CA$156k | CA$150k | -CA$4m |
| Nov 30 2022 | n/a | n/a | -CA$9m |
| Aug 31 2022 | n/a | n/a | -CA$10m |
| May 31 2022 | n/a | n/a | -CA$9m |
| Feb 28 2022 | CA$212k | CA$150k | -CA$8m |
| Nov 30 2021 | n/a | n/a | -CA$2m |
| Aug 31 2021 | n/a | n/a | -CA$2m |
| May 31 2021 | n/a | n/a | -CA$1m |
| Feb 28 2021 | CA$100k | CA$100k | -CA$2m |
| Nov 30 2020 | n/a | n/a | -CA$2m |
| Aug 31 2020 | n/a | n/a | -CA$5m |
| May 31 2020 | n/a | n/a | -CA$5m |
| Feb 29 2020 | CA$765k | CA$272k | -CA$8m |
| Nov 30 2019 | n/a | n/a | -CA$17m |
| Aug 31 2019 | n/a | n/a | -CA$15m |
| May 31 2019 | n/a | n/a | -CA$14m |
| Feb 28 2019 | CA$344k | CA$292k | -CA$11m |
| Nov 30 2018 | n/a | n/a | -CA$3m |
| Aug 31 2018 | n/a | n/a | -CA$2m |
| Feb 28 2018 | CA$412k | CA$341k | -CA$2m |
Compensation vs Market: Mark's total compensation ($USD113.09K) is below average for companies of similar size in the Canadian market ($USD174.31K).
Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.
CEO
Mark Upsdell
7yrs
Tenure
CA$155,597
Compensation
Mr. Mark Andrew Upsdell is the Chief Executive Officer and Director of Rapid Dose Therapeutics Corp. since May 03, 2017 and he served as its Chairman. He serves as President of Rapid Dose Therapeutics Corp...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 7yrs | CA$155.60k | 9.88% CA$ 2.8m | |
| Chief Financial Officer | 4.3yrs | CA$369.38k | no data | |
| Senior Vice President of Business Development | 7yrs | CA$155.60k | no data | |
| Chief Scientist | less than a year | no data | no data | |
| Legal Counsel | no data | no data | no data | |
| Controller | no data | no data | no data | |
| Assistant Corporate Secretary | no data | no data | no data |
5.6yrs
Average Tenure
Experienced Management: DOSE's management team is seasoned and experienced (5.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 7yrs | CA$155.60k | 9.88% CA$ 2.8m | |
| Independent Director | 1.1yrs | no data | no data | |
| Independent Director | 3.8yrs | CA$119.86k | no data | |
| Member Medical of Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | less than a year | no data | 0.0025% CA$ 703.9 | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Advisory Board | 2.4yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
1.7yrs
Average Tenure
Experienced Board: DOSE's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.